Zanubrutinib versus bendamustine and rituximab in untreated patients with CLL/SLL Zanubrutinib versus bendamustine and rituximab in untreated patients with CLL/SLL February 2025 Clinical trials Read more
2020 February Prevention VTE occurrence lowered by adjusting thromboprophylaxis dosages to individual anti-Xa levels Read more
2020 February Prevention BCG vaccine does not increase leukaemia or lymphoma risk, but decreases lung cancer risk Read more
Top
